---

Overview

Bioelectronic medicine is an emerging field at the convergence of molecular medicine, neuroscience and technology with the aim of developing novel diagnostic and therapeutic approaches. This meeting will call international attention to bioelectronic medicine as the platform for new developments in healthcare, technology, and science. Leaders in bioelectronic medicine will discuss current progress, challenges, and future developments.

Summit Chairs:

Yousef Al-Abed, PhD - Professor and Co-Director of The Institute of Bioelectronic Medicine (IBEM) at The Feinstein Institutes for Medical Research (FIMR), and Kenneth Shepard, PhD - Professor of Electrical Engineering, and Co-PI of the NeuroTechnology Center (NTC) at Columbia University.

Key Note Speakers:

Kevin J. Tracey, MD - President and CEO of The Feinstein Institutes for Medical Research and Warren Grill, PhD - Professor of Biomedical Engineering, Duke University.

Scientific Advisory Committee:

Eric Chang, PhD | Timir Datta, PhD | Anil K. Malhotra, MD | JoJo Platt, Neurotech Strategist| Stavros Zanos, MD, PhD | Theodoros Zanos, PhD.

Program

Day One: Tuesday, October 11, 2022 (08:00a - 08:00p)

Opening Remarks & Welcome: Yousef Al-Abed, PhD | Kenneth Shepard, PhD
Key Note Address: Kevin J. Tracey, MD

Session 1: Neurotechnology in the treatment of brain diseases: Successes, challenges, and new frontiers. This session will focus on discussions of the technological, translational and clinical development aspects of bioelectronic therapies for brain disorders.
Host: Stavros Zanos, MD, PhD
Moderator: Robert Froemke, PhD, New York University
Panelists: Riki Banerjee, PhD, Synchron | Florian Solzbacher, PhD, University of Utah| Tim Denison PhD, University of Oxford | Further confirmations forthcoming

Session 2: Neural regulation of immunity: Controlling the immune response through the peripheral nervous system: This session will cover recent advances in neuro-immunology, with a focus on bi-directional communication between the nervous system and immune system.
Host: Eric Chang, PhD
Panelists: Gloria Choi, PhD, M.I.T. | Asya Rolls, PhD, Technion | Brian S. Kim, MD, Mount Sinai | Jeremy Borniger, PhD, Cold Spring Harbor Laboratory

Session 3: Emerging devices and neural interfaces: Does innovation happen by addressing known gaps in technology or is it best driven by addressing researcher needs? This session will focus on new technologies and interfaces for stimulation and biosensing including electrical, optical, chemical, ultrasound, and other novel approaches. Investigators will discuss their perspective on, and past experience in, developing new technologies either in response to existing needs or as a means to enable new approaches.
Host: Timir Datta, PhD
Moderator: Eric Van Gieson, PhD, DARPA• Panelists: Flavia Vitale , PhD, University of Pennsylvania |Shadi Dayeh, PhD, UCSD | Jesse Wheeler, PhD, Inner Cosmos

Session 4: Decoding of Neural Signals and the use of data science and machine learning in neural systems as applied to bioelectronic medicine. This session will focus on the efforts to understand how the computations performed by neurons relate to perception, movement, memory and other complex behaviors, and the decoding algorithms developed to translate sensory and motor neural signals into volition, perception, mental and disease states. Host and Moderator: Theodoros Zanos, PhD
Panelists: Maryam Shanechi, PhD, USC | Konrad Koerding, PhD, University of Pennsylvania | Lorenzo Rossi, PhD, WebBioBank – Newronika | Sridevi Sarma, PhD, Johns Hopkins

Session 5: Bioelectronic medicine for neuropsychiatric disorder. This session will feature discussions on 1: Neuro-vascular modulation: How electrical stimulation activates vascular function and why it matters, 2: Transcranial magnetic stimulation for drug and alcohol use disorders: state of the science, 3: Recent advances in personalizing brain stimulation: connectivity, anatomy and EEG, 4: Electrical field modeling and electroconvulsive therapy.
Host & Moderator: Anil Malhotra, MD
Panelists: Marom Bikson, PhD, The City College of New York of CUNY | Colleen Hanlon, PhD, Wake Forest School of Medicine | Daphne Voineskos, PhD, University of Toronto | Miklos Argyelan, MD, Feinstein Institutes for Medical Research

DAY 1: POST MEETING EVENTS

05:15p: Poster Session & Cocktail Hour
06:30p: Dinner Buffet

Day Two: Wednesday, October 12, 2022

Welcome: Kevin J. Tracey, MD
Key Note Address: Warren Grill, PhD

Session 6: Bioelectronic approaches to the treatment of peripheral organ disorders. This session will focus on discussions of the scientific, translational and clinical aspects of bioelectronic therapies targeting the peripheral nervous system to treat complex disorders of immunity, cardiovascular system, metabolism and others.
Host: Stavros Zanos, MD
Moderator: Eric Hudak, PhD, NIH
Panelists: Jeffery Ardell, PhD, UCLA | Kevin Otto, PhD, UF | Dennis Bourbeau, PhD, Case Western Reserve University

Session 7: Neurotech - The journey from bench to bedside. A look at how, when, and where neurotechnology makes its way through commercialization featuring the insights and expertise of a world renown neurotechnology researcher, a neurotech investor, a development leader of one of the leading strategic partners in the field, and the CEO of a publicly traded neurotechnology company. In this session, we’ll discuss different pathways and opportunities at every turn of the development arc as well as new and notable trends in commercial neurotech.
Host: JoJo Platt, President, Platt & Associates, Inc
Moderator: Sarah Lisanby, M.D. - NIH/NIMH - Director, Noninvasive Neuromodulation Unit
Panelists: Stephanie Lacour, PhD, EPFL | Erika Ross, PhD, Abbott | Jennifer Ernst, PhD, Tivic Health | Amy Kruse, PhD, Prime Movers Lab

Session 8: Bioelectronic data in the wild: Using digital health data from consumer and clinical devices to inform biomarkers of disease and treatment efficacy, device deployment and trial recruitment: This session will focus on the efforts to use various physiological data modalities, combined with computational algorithms, to reveal biomarkers of certain conditions as well as treatment efficacy, enhancing our ability for targeted device deployment and clinical trial recruitment.
Host: Theodoros Zanos, PhD
Moderator: Erika Ross, PhD, R&D Applied Research
Panelists: Omer Inan, Georgia Tech | Brian Pepin, CEO - Rune Labs | Further confirmations forthcoming

Session 9: Translating Brain Computer Interfaces: are we reaching an inflection point? The panel will discuss the specific needs of patient populations, and identify key technical, regulatory and commercial roadblocks to widespread patient adoption. It will also review untapped potential and the opportunities of developing meaningful and transparent performance metrics.
Implantable Brain Computer Interfaces (BCIs) appear to be heading towards an inflection point: in the past decade, the number and frequency of technological breakthroughs has increased significantly. The first generations of commercially available products appear to be imminent. These devices have the ability to become tangible tools to restore lost function and address a variety of neurological disorders. The real life settings associated with in-home use will inevitably lead to reprioritization of technological advancements as well as the emergence of novel practical and fundamental challenges and opportunities. How do we identify and prioritize user, clinician and caretaker needs? What is possible today and what is a realistic roadmap that meets those needs? How does this affect the focus of public and private investments?
Host: Florian Solzbacher, PhD, Co-Founder and Chairman – Blackrock Neurotech
Moderator: Robert Gaunt, PhD, University of Pittsburgh
Panelists: Matt Angle, PhD, CEO - Paradromics | Robert Franklin, PhD, Blackrock Neurotech | Jennifer Collinger, PhD, University of Pittsburgh

DAY 2: POST MEETING EVENTS

~04:45p: Cocktail Reception & Networking

For more information regarding poster submission and registration please visit the link below

Learn more